Compare CRMT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRMT | RPID |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 204.3M |
| IPO Year | 2026 | 2021 |
| Metric | CRMT | RPID |
|---|---|---|
| Price | $18.31 | $4.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $37.00 | $8.00 |
| AVG Volume (30 Days) | 75.6K | ★ 138.6K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.36 | 11.48 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,390,932,000.00 | $28,051,000.00 |
| Revenue This Year | $2.41 | $19.91 |
| Revenue Next Year | $4.65 | $21.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 24.57 |
| 52 Week Low | $17.78 | $1.86 |
| 52 Week High | $62.55 | $4.94 |
| Indicator | CRMT | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 29.93 | 50.27 |
| Support Level | $17.78 | $2.92 |
| Resistance Level | $28.59 | $4.49 |
| Average True Range (ATR) | 1.39 | 0.28 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 16.16 | 47.13 |
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.